FDA approves sublingual apomorphine in off periods

22 de July de 2020

The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s disease with motor fluctuations. We have led the clinical trial in Spain with this drug. Our patients are continuing to use it during the open label extension.

CategoryParkinson, Uncategorised

An option to modify the course of Parkinson’s progression

21 de November de 2023

Evaluation of an inhibitor of the LRRK 2 gene in Parkinson’s patients. Oral tract. We…

Posted in: Parkinson

An option for patients with Parkinson’s and LRRK2 mutation

21 de November de 2023

Trial on LRRK2 mutation in Parkinson’s is about to be completed. Our Trials Unit is…

Posted in: Parkinson

Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusion

8 de May de 2023

Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…

Posted in: Parkinson

New inhaled levodopa INBRIJA authorised in Spain

8 de May de 2023

The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…

Posted in: Parkinson

new drug for early-stage Alzheimer’s disease

16 de January de 2023

On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…

Posted in: Alzeimer, Alzeimer, News, Uncategorised

We tested a drug to treat agitation in Alzheimer’s patients

3 de June de 2021

The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…

Posted in: Alzeimer, Uncategorised

hospital general projecte alzheimer 37 1600x800 1

The General University Hospital of Catalonia (HUGC), through the Clinical Research Unit (UDIC), has included the world’s first patient in a phase I clinical trial on Alzheimer’s.

3 de June de 2021

This study could improve the efficacy and safety of the products being evaluated to try…

Posted in: Alzeimer, Uncategorised

US authorizes an intranasal levodopa.

8 de April de 2020

An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….

Posted in: Parkinson

↑

No dude en llamarnos  1-+34 935 656 000



Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that guarantee basic functionalities and security features of the website. These cookies do not store any personal information.

Cookie	Duration	Description
cookielawinfo-checkbox-necessary	11 mesos	Aquesta cookie la defineix el connector de consentiment de cookies de GDPR. Les cookies s’utilitzen per emmagatzemar el consentiment de l’usuari per a les cookies de la categoria “Necessàries”.
cookielawinfo-checkbox-non-necessary	11 mesos	Aquesta cookie la defineix el connector de consentiment de cookies de GDPR. Les cookies s'utilitzen per emmagatzemar el consentiment de l'usuari per a les cookies de la categoria "No necessàries".
viewed_cookie_policy	11 mesos	La cookie la defineix el connector de consentiment de cookies de GDPR i s’utilitza per emmagatzemar si l’usuari ha consentit o no l’ús de cookies. No emmagatzema cap dada personal.

Uncategorized

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics, number of visitors, bounce rate, traffic source, and more.

Cookie	Duration	Description
_ga	2 anys	Aquesta cookie és instal·lada per Google Analytics. La cookie s’utilitza per calcular dades de visitants, sessions, camapign i fer un seguiment de l’ús del lloc per a l’informe d’anàlisi del lloc. Les cookies emmagatzemen informació de forma anònima i assignen un número generat aleatòriament per identificar visitants únics.
_gat_gtag_UA_174011454_1	1 minut	Google utilitza aquesta cookie per distingir els usuaris.
_gid	1 dia	Aquesta cookie és instal·lada per Google Analytics. La cookie s’utilitza per emmagatzemar informació sobre com els visitants fan servir un lloc web i ajuda a crear un informe d’anàlisi de com està funcionant el lloc web. Les dades recopilades, inclosos el nombre de visitants, la font d’on han vingut, i les pàgines visitats de forma anònima.

Related Stories